CHRW: Jury Awards $604M Verdict

As of 2026-07-24, the core event is a Dallas jury issuing an advisory verdict for $604 million against C.H. Robinson (CHRW). The documents supplied for this article do not include company filings such as 10-Ks, 10-Qs, earnings releases, or regulatory disclosures that would be needed to analyze CHRW’s financial position, potential liability recognition, or management commentary. The only primary-source filings available in the provided material are institutional Form 13F filings from two separate investment managers—Robinson Capital Management, LLC and Robinson Value Management, Ltd.—covering holdings snapshots (not company operational or legal disclosures) as of Q4 2025 and Q3 2025. Those 13F documents report investment positions and do not address litigation outcomes, contingent liabilities, or company responses.

Given the limited record available here, investors seeking to assess the potential financial and operational impact of the $604M advisory verdict should consult CHRW’s official regulatory filings and investor materials. Recommended sources (consistent with the materials referenced in the provided company profile) include: - C.H. Robinson’s SEC filings (Form 10-K and most recent Form 10-Q) via EDGAR for consolidated financial statements, notes, and management discussion and analysis (MD&A). - The company’s investor relations page and any press releases or earnings call transcripts for management commentary and litigation disclosures. - Professional market data providers or regulatory dockets for court documents and status updates on the advisory verdict and any appeals or settlements. The provided recommendation list explicitly suggests these steps to obtain the detailed financial and operational information necessary for a full assessment.